S. Hadad

发表

A prospective comparison of ER, PR, Ki67 and gene expression in paired sequential core biopsies of primary, untreated breast cancer

L. Pusztai, A. Thompson, C. Purdie, 2015, BMC Cancer.

The NeST (Neoadjuvant systemic therapy in breast cancer) study: National Practice Questionnaire of United Kingdom multi-disciplinary decision making

S. Irshad, C. Coles, T. Crook, 2021, BMC cancer.

Predicting Patients Found to Have Malignancy at Nipple Duct Surgery

C. Cartlidge, S. Hadad, S. Kohlhardt, 2019, Breast Care.

Abstract S2-03: Preoperative window of opportunity study of the PI3K inhibitor pictilisib (GDC-0941) plus anastrozole vs anastrozole alone in patients with ER+, HER2-negative operable breast cancer (OPPORTUNE study)

A. Purushotham, S. Pinder, A. Thompson, 2015 .

Delay from Symptom Onset Increases the Conversion Rate in Laparoscopic Cholecystectomy for Acute Cholecystitis

J. Vaidya, S. Hadad, T. Heron, 2007, World Journal of Surgery.

Phase II Randomized Preoperative Window-of-Opportunity Study of the PI3K Inhibitor Pictilisib Plus Anastrozole Compared With Anastrozole Alone in Patients With Estrogen Receptor-Positive Breast Cancer.

A. Purushotham, S. Pinder, T. Wilson, 2016, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Metformin Promotes Antitumor Immunity via Endoplasmic-Reticulum-Associated Degradation of PD-L1.

W. Symmans, M. Hung, Seung-Oe Lim, 2018, Molecular cell.

A candidate molecular signature associated with tamoxifen failure in primary breast cancer

C. Nguyen, I. Bièche, A. Thompson, 2008, Breast Cancer Research.

Histological evaluation of AMPK signalling in primary breast cancer

Philip R Quinlan, Lee Baker, Alastair M Thompson, 2009, BMC Cancer.

Targeting AMPK: a new therapeutic opportunity in breast cancer.

A. Thompson, S. Fleming, S. Hadad, 2008, Critical reviews in oncology/hematology.

Effects of metformin on breast cancer cell proliferation, the AMPK pathway and the cell cycle

A. Thompson, S. Hadad, V. Appleyard, 2013, Clinical and Translational Oncology.

Evidence for biological effects of metformin in operable breast cancer: a pre-operative, window-of-opportunity, randomized trial

L. Pusztai, A. Thompson, J. Dewar, 2011, Breast Cancer Research and Treatment.

Evidence for biological effects of metformin in operable breast cancer: biomarker analysis in a pre-operative window of opportunity randomized trial

A. Thompson, C. Purdie, P. Goodwin, 2015, Breast Cancer Research and Treatment.

S. Hadad, Seerwan Qaradaghy, 2020, Clinical case reports.

Delay from Symptom Onset Increases the Conversion Rate in Laparoscopic Cholecystectomy for Acute Cholecystitis

J. Vaidya, S. Hadad, K. Hussain, 2008, World Journal of Surgery.

Therapeutic metformin/AMPK activation promotes the angiogenic phenotype in the ERα negative MDA-MB-435 breast cancer model

Alastair M. Thompson, A. Thompson, Sirwan M. Hadad, 2009, Breast Cancer Research and Treatment.

αB-crystallin, vimentin and increased p53 expression levels in breast cancer is associated with poor prognosis.

C. Purdie, P. Quinlan, S. Bray, 2009 .

Effects of prolonged exposure to low dose metformin in thyroid cancer cell lines

S. Balasubramanian, K. Sisley, S. Hadad, 2017, Journal of Cancer.